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Despite recent advances in neonatal care, neo natal 
sep sis remains an important cause of illness and 
death among infants admitted to the neonatal in-
ten sive care unit (NICU).1−5 The overall case-fatality 
rates from neonatal sepsis range from 2% to as high 
as 50%.6 Antibiotics are increasingly used in new-
born care to deal with this important problem. How-
ever, there is concern that the increased use of 
antibiotics might result in a change in the spectrum 
of organisms and/or their susceptibilities to anti-
biotics.7−10 Over the years, several studies have 
shown changes in epidemiologic trends of neonatal 
sepsis.4,11−14 Furthermore, temporal and geographic 
differences in the relative frequencies of various 
neonatal pathogens are well recognized.11,15−17
In order to make effective decisions regarding 
em piric antibiotic therapy, surveillance of ordinary 
causative microorganisms in each NICU is required. 
In this issue of the journal, Wu et al report on their 
sur veillance study of neonatal sepsis in the NICU 
of a tertiary medical center in northern Taiwan.18 
They found that most neonates with early-onset sep-
sis were term infants, while very-low-birth-weight 
(VLBW) and preterm infants accounted for the ma-
jority of cases of late-onset sepsis. In ear ly-onset 
sepsis, the leading pathogens responsible were group 
B streptococci (GBS) and Escherichia coli. GBS were 
associated with more meningitis but lower mortal-
ity than E. coli. The most common pathogens in-
volved in late-onset sepsis were co agulase-negative 
staphylococci and Candida. The sepsis-related mor-
tality rates were higher for early-onset sepsis (10%) 
than late-onset sepsis (7%). They also suggested that 
GBS screening and intrapartum antibiotic prophyl 
(IAP) guidelines should be popularized in Taiwan to 
prevent neonatal early-onset sepsis. Although, this 
report provides us with information on the epide-
miologic trends in this NICU, several issues must be 
addressed before general implementation of GBS 
screening and IAP guidelines in Taiwan.
The first such issue concerns the study pop ulation. 
This report is based on surveillance of neonates 
ad mitted to a single NICU. It is not a population-
based study, and whether or not its results can be 
applied to the general population in Taiwan is still 
unknown. A well-conducted pop ulation-based pro-
spective study should answer this question.
The second issue is that this report reveals that 
most neonates with early-onset sepsis were term 
infants, while VLBW and preterm infants accounted 
for the majority of cases of late-onset sepsis. This 
is a very interesting finding and is quite different 
from those reported in a previous study. Benitz and 
associates performed a data analysis of risk factors 
for early-onset GBS sepsis from the 1970s to the 1990s 
to generate odds ratio estimates for several clini-
cal factors. In their study, the neonatal risk fac tors 
predictive of early-onset GBS sepsis included pre-
maturity (< 37 weeks’ gestation), and low birth weight 
(< 2500 g), especially a birth weight < 1000 g.19 From 
a practical point of view, it is not useful to demon-
strate that most neonates with early-onset sepsis 
were term infants, while VLBW and preterm infants 
accounted for the majority of cases of late-onset 
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sepsis. Instead, the identification of risk factors such 
as prematurity and low birth weight are more help-
ful in clinical decision-making.
The third issue relates to the cost-effectiveness 
analysis of generalized GBS screening and the appli-
cation of IAP guidelines recommended by the CDC. 
Strategies based on screening for GBS colonization 
using rectovaginal cultures at 36 weeks’ ges tation, 
or using a rapid test to screen for GBS colonization 
on presentation for delivery, combining intrapartum 
prophylaxis for selected mothers and postpartum 
prophylaxis for some of their infants, would require 
treatment of fewer patients and prevent more cases 
(78.4% or 80.1%, respectively) at lower costs.20
Finally, even after widespread implementation 
of GBS screening and IAP guidelines in United States, 
there is a coincident finding that Gram-negative en-
teric bacteria have become the leading cause of EOS 
in preterm infants.14,21 Again, we need to be careful 
about the generalized implementation of GBS screen-
ing and IAP guidelines; more studies are needed 
to evaluate their benefits/costs in the neonatal 
population.
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